CN1282249A - 用于治疗阳痿和增强性唤起的前列腺素E2/F2α组合剂 - Google Patents

用于治疗阳痿和增强性唤起的前列腺素E2/F2α组合剂 Download PDF

Info

Publication number
CN1282249A
CN1282249A CN 98812205 CN98812205A CN1282249A CN 1282249 A CN1282249 A CN 1282249A CN 98812205 CN98812205 CN 98812205 CN 98812205 A CN98812205 A CN 98812205A CN 1282249 A CN1282249 A CN 1282249A
Authority
CN
China
Prior art keywords
pge
prostaglandin
urethra
composition
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 98812205
Other languages
English (en)
Chinese (zh)
Inventor
内森·厄尔·斯科特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/992,946 external-priority patent/US5981593A/en
Priority claimed from US09/038,378 external-priority patent/US5962528A/en
Application filed by Individual filed Critical Individual
Publication of CN1282249A publication Critical patent/CN1282249A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN 98812205 1997-12-18 1998-12-15 用于治疗阳痿和增强性唤起的前列腺素E2/F2α组合剂 Pending CN1282249A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/992,946 1997-12-18
US08/992,946 US5981593A (en) 1991-07-03 1997-12-18 Prostaglandin E2 treatment of impotence
US508798A 1998-01-09 1998-01-09
US09/005,087 1998-01-09
US09/038,378 1998-03-11
US09/038,378 US5962528A (en) 1991-07-03 1998-03-11 Prostaglandin E2 /F2α combination for treating impotence

Publications (1)

Publication Number Publication Date
CN1282249A true CN1282249A (zh) 2001-01-31

Family

ID=27357802

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 98812205 Pending CN1282249A (zh) 1997-12-18 1998-12-15 用于治疗阳痿和增强性唤起的前列腺素E2/F2α组合剂

Country Status (5)

Country Link
EP (1) EP1059926A2 (fr)
CN (1) CN1282249A (fr)
AU (1) AU1827299A (fr)
CA (1) CA2314369A1 (fr)
WO (1) WO1999030718A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251436B1 (en) * 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
WO2000051978A1 (fr) 1999-03-01 2000-09-08 Nitromed, Inc. Prostaglandines nitrosees et nitrosylees, compositions et methodes d'utilisation
ATE281432T1 (de) 1999-03-05 2004-11-15 Univ Duke C-16 ungesätigte fp-selektive prostaglandin analoge
AU3724400A (en) * 1999-03-08 2000-09-28 Merck & Co., Inc. Methods and compositions for treating erectile dysfunction
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
IL139457A0 (en) * 1999-11-08 2001-11-25 Pfizer Compounds for the treatment of female sexual dysfunction
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
EP1280531B1 (fr) * 2000-05-12 2007-01-24 Novalar Pharmaceuticals, Inc. Formulation consistée de phentolamine mesylate et son utilisation
SE0100158D0 (sv) * 2001-01-19 2001-01-19 Synphora Ab Novel method and composition for local treatment of Meniere´s disease and tinnitus
AU2009301392B9 (en) * 2008-10-10 2018-05-24 Implantica Patent Ltd. Stimulation of sexually responsive tissue of the vulva
US9757330B2 (en) 2013-10-18 2017-09-12 Industrial Technology Research Institute Recipe for in-situ gel, and implant, drug delivery system formed thereby

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917864A (en) * 1973-02-12 1975-11-04 Sultanali M M Karim Use of prostaglandins E and F for induction of labor
US4005221A (en) * 1974-04-01 1977-01-25 Karim Sultanali M M Use of prostaglandins to induce menstruation
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
ZA912984B (en) * 1990-04-25 1992-01-29 Alza Corp Treatment of erectile dysfunction
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
AU2300092A (en) * 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment

Also Published As

Publication number Publication date
WO1999030718A3 (fr) 1999-09-10
AU1827299A (en) 1999-07-05
EP1059926A2 (fr) 2000-12-20
CA2314369A1 (fr) 1999-06-24
WO1999030718A2 (fr) 1999-06-24

Similar Documents

Publication Publication Date Title
US5708031A (en) Prostaglandin E2 treatment of impotence
CN1103589C (zh) 调节人体性反应的方法
RU2207845C2 (ru) Твердая лекарственная форма пролонгированного действия для парентерального введения и способ ее получения
AU773144B2 (en) Drug preparations for treating sexual dysfunction
US5474535A (en) Dosage and inserter for treatment of erectile dysfunction
AU655420B2 (en) Treatment of erectile dysfunction
JP5675865B2 (ja) 女性の尿失禁を治療するための用具および方法
CN1282249A (zh) 用于治疗阳痿和增强性唤起的前列腺素E2/F2α组合剂
JPH10505611A (ja) 勃起機能不全を予防するための方法およびキット
US20040043071A1 (en) Intravaginal mucosal or transmucosal delivery of antimigraine and antinausea drugs
EA000566B1 (ru) Стабильный однородный крем на основе нитроглицерина для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений
US5925629A (en) Transurethral administration of androgenic agents for the treatment of erectile dysfunction
US6291528B1 (en) Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal
WO1999038472A2 (fr) Composition de gel de vasodilatation topique et ses methodes d'utilisation et de production
US5962528A (en) Prostaglandin E2 /F2α combination for treating impotence
US5981593A (en) Prostaglandin E2 treatment of impotence
CN108309931B (zh) 一种治疗滑膜炎的制剂及其制备方法
RU2249449C2 (ru) Гинекологические овули с дибунолом для лечения воспалительных заболеваний
JP2014518851A (ja) 肛門直腸疾患の処置のためのオキシメタゾリン
CN113694011A (zh) 一种直肠给药以局部作用治疗便秘的药物及其制备方法
ES2326374T3 (es) Composiciones vaginales para el tratamiento de infecciones y traumas del tejido pelvico.
CA2243657C (fr) Composition pour le traitement de la dysfonction erectile
JPS649964B2 (fr)
RU2249448C2 (ru) Суппозитории с дибунолом и экстрактом прополиса для лечения гинекологических воспалительных заболеваний
CA2498457C (fr) Composition pour le traitement des hemorroides

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CI01 Publication of corrected invention patent application

Correction item: Applicant address

Correct: American California

False: California State of evil

Number: 5

Page: 115

Volume: 17

CI02 Correction of invention patent application

Correction item: Applicant address

Correct: American California

False: California State of evil

Number: 5

Page: The title page

Volume: 17

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT ADDRESS; FROM: MEIGUOJIALIFUNIE STATE TO: CALIFORNIA, USA

ERR Gazette correction

Free format text: CORRECT: APPLICANT ADDRESS; FROM: MEIGUOJIALIFUNIE STATE TO: CALIFORNIA, USA

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication